200 related articles for article (PubMed ID: 20972631)
1. Identification of a large rearrangement in CYLD as a cause of familial cylindromatosis.
van den Ouweland AM; Elfferich P; Lamping R; van de Graaf R; van Veghel-Plandsoen MM; Franken SM; Houweling AC
Fam Cancer; 2011 Mar; 10(1):127-32. PubMed ID: 20972631
[TBL] [Abstract][Full Text] [Related]
2. Mutations in the CYLD gene in Brooke-Spiegler syndrome, familial cylindromatosis, and multiple familial trichoepithelioma: lack of genotype-phenotype correlation.
Bowen S; Gill M; Lee DA; Fisher G; Geronemus RG; Vazquez ME; Celebi JT
J Invest Dermatol; 2005 May; 124(5):919-20. PubMed ID: 15854031
[TBL] [Abstract][Full Text] [Related]
3. Brooke-Spiegler syndrome: report of a case of multiple cylindromas and trichoepitheliomas.
Doherty SD; Barrett TL; Joseph AK
Dermatol Online J; 2008 Jul; 14(7):8. PubMed ID: 18718192
[TBL] [Abstract][Full Text] [Related]
4. Phenotype variability in tumor disorders of the skin appendages associated with mutations in the CYLD gene.
Parren LJMT; Giehl K; van Geel M; Frank J
Arch Dermatol Res; 2018 Sep; 310(7):599-606. PubMed ID: 29974194
[TBL] [Abstract][Full Text] [Related]
5. CYLD mutations underlie Brooke-Spiegler, familial cylindromatosis, and multiple familial trichoepithelioma syndromes.
Young AL; Kellermayer R; Szigeti R; Tészás A; Azmi S; Celebi JT
Clin Genet; 2006 Sep; 70(3):246-9. PubMed ID: 16922728
[TBL] [Abstract][Full Text] [Related]
6. Brooke-Spiegler syndrome: report of two cases not associated with a mutation in the CYLD and PTCH tumor-suppressor genes.
Ponti G; Nasti S; Losi L; Pastorino L; Pollio A; Benassi L; Giudice S; Bertazzoni G; Veratti E; Azzoni P; Bianchi Scarrà G; Seidenari S
J Cutan Pathol; 2012 Mar; 39(3):366-71. PubMed ID: 22077640
[TBL] [Abstract][Full Text] [Related]
7. Identification of a recurrent mutation in the CYLD gene in Brooke-Spiegler syndrome.
Scheinfeld N; Hu G; Gill M; Austin C; Celebi JT
Clin Exp Dermatol; 2003 Sep; 28(5):539-41. PubMed ID: 12950348
[TBL] [Abstract][Full Text] [Related]
8. A novel missense mutation in CYLD in a family with Brooke-Spiegler syndrome.
Hu G; Onder M; Gill M; Aksakal B; Oztas M; Gürer MA; Celebi JT
J Invest Dermatol; 2003 Oct; 121(4):732-4. PubMed ID: 14632188
[TBL] [Abstract][Full Text] [Related]
9. Multiple (familial) trichoepitheliomas: a clinicopathological and molecular biological study, including CYLD and PTCH gene analysis, of a series of 16 patients.
Kazakov DV; Vanecek T; Zelger B; Carlson JA; Spagnolo DV; Schaller J; Nemcova J; Kacerovska D; Vazmitel M; Sangüeza M; Emberger M; Belousova I; Fernandez-Figueras MT; Kempf W; Meyer DR; Rütten A; Baltaci M; Michal M
Am J Dermatopathol; 2011 May; 33(3):251-65. PubMed ID: 21389835
[TBL] [Abstract][Full Text] [Related]
10. [Brooke-Spiegler syndrome: an heterogeneous entity].
Mataix J; Bañuls J; Botella R; Laredo C; Lucas A
Actas Dermosifiliogr; 2006 Dec; 97(10):669-72. PubMed ID: 17173833
[TBL] [Abstract][Full Text] [Related]
11. Large germline deletions of the CYLD gene in patients with Brooke-Spiegler syndrome and multiple familial trichoepithelioma.
Vanecek T; Halbhuber Z; Kacerovska D; Martinek P; Sedivcova M; Carr RA; Slouka D; Michal M; Kazakov DV
Am J Dermatopathol; 2014 Nov; 36(11):868-74. PubMed ID: 25347032
[TBL] [Abstract][Full Text] [Related]
12. Diverse phenotype of Brooke-Spiegler syndrome associated with a nonsense mutation in the CYLD tumor suppressor gene.
Zhang G; Huang Y; Yan K; Li W; Fan X; Liang Y; Sun L; Li H; Zhang S; Gao M; Du W; Yang S; Liu J; Zhang X
Exp Dermatol; 2006 Dec; 15(12):966-70. PubMed ID: 17083363
[TBL] [Abstract][Full Text] [Related]
13. Five new CYLD mutations in skin appendage tumors and evidence that aspartic acid 681 in CYLD is essential for deubiquitinase activity.
Almeida S; Maillard C; Itin P; Hohl D; Huber M
J Invest Dermatol; 2008 Mar; 128(3):587-93. PubMed ID: 17851586
[TBL] [Abstract][Full Text] [Related]
14. A case of Brooke-Spiegler syndrome with a new mutation in the CYLD gene.
Heinritz W; Grunewald S; Strenge S; Schütz A; Froster UG; Glander HJ; Paasch U; Simon JC
Br J Dermatol; 2006 May; 154(5):992-4. PubMed ID: 16634909
[No Abstract] [Full Text] [Related]
15. Mild phenotype of familial cylindromatosis associated with an R758X nonsense mutation in the CYLD tumour suppressor gene.
Oiso N; Mizuno N; Fukai K; Nakagawa K; Ishii M
Br J Dermatol; 2004 Nov; 151(5):1084-6. PubMed ID: 15541090
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous appendage tumors: familial cylindromatosis and associated tumors update.
Lian F; Cockerell CJ
Adv Dermatol; 2005; 21():217-34. PubMed ID: 16350444
[No Abstract] [Full Text] [Related]
17. Trichoepithelioma.
Johnson H; Robles M; Kamino H; Walters RF; Lee A; Sanchez M
Dermatol Online J; 2008 Oct; 14(10):5. PubMed ID: 19061604
[TBL] [Abstract][Full Text] [Related]
18. Loss of the tumor suppressor CYLD enhances Wnt/beta-catenin signaling through K63-linked ubiquitination of Dvl.
Tauriello DV; Haegebarth A; Kuper I; Edelmann MJ; Henraat M; Canninga-van Dijk MR; Kessler BM; Clevers H; Maurice MM
Mol Cell; 2010 Mar; 37(5):607-19. PubMed ID: 20227366
[TBL] [Abstract][Full Text] [Related]
19. A mutational hotspot in CYLD causing cylindromas: a comparison of phenotypes arising in different genetic backgrounds.
Nagy N; Rajan N; Farkas K; Kinyó A; Kemény L; Széll M
Acta Derm Venereol; 2013 Nov; 93(6):743-5. PubMed ID: 23584127
[No Abstract] [Full Text] [Related]
20. The CYLD p.R758X worldwide recurrent nonsense mutation detected in patients with multiple familial trichoepithelioma type 1, Brooke-Spiegler syndrome and familial cylindromatosis represents a mutational hotspot in the gene.
Farkas K; Deák BK; Sánchez LC; Martínez AM; Corell JJ; Botella AM; Benito GM; López RR; Vanecek T; Kazakov DV; Kromosoeto JN; van den Ouweland AM; Varga J; Széll M; Nagy N
BMC Genet; 2016 Feb; 17():36. PubMed ID: 26861065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
